Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Drug Development

      Merck Collaborates with Mammoth Biosciences to Scale New SARS-CoV-2 Test

      Drug Development
      Merck, a leading science and technology company, announced a collaboration with Mammoth Biosciences Inc., of South San Francisco, California, USA, for the development, scale-up...

      FDA Approves Expanded Indication for Merck’s KEYTRUDA in Adult Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

      FDA Approvals
      Merck, known as MSD outside the United States and Canada, announced that the U.S. FDA has approved an expanded label for KEYTRUDA, Merck’s anti-PD-1...

      Dr.Reddy’s and RDIF receive approval to conduct clinical trial for Sputnik V vaccine in India

      Clinical Trials
      Dr.Reddy’s Laboratories Ltd. and Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, today announced that they have received approval from the DrugsControllerGeneral of...

      NIH initiates phase 3 clinical trial to test immune modulators for treatment of COVID-19

      Clinical Trials
      The National Institutes of Health (NIH) has launched an adaptive phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator...

      BD Gets CE Mark for COVID-19 Application of Immune Function Assay

      Drug Development
      BD (Becton, Dickinson and Company), a leading global medical technology company, announced the CE mark and European availability of a product for assessing immune...

      Amgen Announces Positive Topline Phase 2 Results For Investigational KRAS G12C Inhibitor Sotorasib In Lung Cancer

      Clinical Trials
      Amgen announced positive topline Phase 2 results from the CodeBreaK 100 clinical study, evaluating sotorasib (proposed INN for AMG 510) in 126 patients with...

      BMS Presents Positive Late-Breaking Data from Phase 3 True North Trial Evaluating Zeposia

      Clinical Trials
      Bristol Myers Squibb announced detailed results from True North, a pivotal, placebo-controlled Phase 3 trial evaluating oral Zeposia (ozanimod) as an induction and maintenance...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.